|
|
X4 Pharmaceuticals Inc (NASDAQ: XFOR) |
|
|
|
Cumulative X4 Pharmaceuticals Inc's Interest Coverage ratios
XFOR's Interest expense and Ebitda growth
Select the Comparisons :
|
|
Select the Ratio:
|
|
XFOR Interest Coverage |
(Mar 31 2025) I. Quarter |
(Dec 31 2024) IV. Quarter |
(Sep 30 2024) III. Quarter |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
Y / Y Interest expense Change |
- |
295.59 % |
110.28 % |
96.21 % |
63.81 % |
Y / Y Ebitda Change |
- |
- |
- |
- |
- |
Interest Coverage (TTM) |
2.46 |
- |
1.1 |
- |
- |
Interest Coverage Ranking |
# |
# |
# |
# |
# |
Seq. Interest expense Change |
- |
167.77 % |
10.94 % |
16.12 % |
14.69 % |
Seq. Ebitda Change |
- |
- |
- |
- |
- |
Interest Coverage in the first quarter 2025 Comment |
X4 Pharmaceuticals Inc's interest coverage sequentially grew from the fourth quarter 2024 to 2.46in the Q1 2025, above company average.
Within Healthcare sector X4 Pharmaceuticals Inc achieved highest interest coverage ratio in the first quarter 2025. While interest coverage ratio ranking remained unchanged compared to the fourth quarter 2024 at no. 0.
What is Interest Coverage Ratio?
Source of X4 Pharmaceuticals Inc sales
|
Interest Coverage Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
Interest Coverage Statistics |
High |
Average |
Low |
0 |
0 |
0 |
|
|
|
|
Date modified: 2025-05-23T09:22:02+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com